Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1007/s13402-024-01007-8.

Title:
Cell death in glioblastoma and the central nervous system | Cellular Oncology
Description:
Glioblastoma is the commonest and deadliest primary brain tumor. Glioblastoma is characterized by significant intra- and inter-tumoral heterogeneity, resistance to treatment and dismal prognoses despite decades of research in understanding its biological underpinnings. Encompassed within this heterogeneity and therapy resistance are severely dysregulated programmed cell death pathways. Glioblastomas recapitulate many neurodevelopmental and neural injury responses; in addition, glioblastoma cells are composed of multiple different transformed versions of CNS cell types. To obtain a greater understanding of the features underlying cell death regulation in glioblastoma, it is important to understand the control of cell death within the healthy CNS during homeostatic and neurodegenerative conditions. Herein, we review apoptotic control within neural stem cells, astrocytes, oligodendrocytes and neurons and compare them to glioblastoma apoptotic control. Specific focus is paid to the Inhibitor of Apoptosis proteins, which play key roles in neuroinflammation, CNS cell survival and gliomagenesis. This review will help in understanding glioblastoma as a transformed version of a heterogeneous organ composed of multiple varied cell types performing different functions and possessing different means of apoptotic control. Further, this review will help in developing more glioblastoma-specific treatment approaches and will better inform treatments looking at more direct brain delivery of therapeutic agents.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {šŸ“š}

  • Education
  • Science
  • Telecommunications

Content Management System {šŸ“}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {šŸ“ˆ}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,019 visitors per month in the current month.
However, some sources were not loaded, we suggest to reload the page to get complete results.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {šŸ’ø}

We find it hard to spot revenue streams.

Many websites are intended to earn money, but some serve to share ideas or build connections. Websites exist for all kinds of purposes. This might be one of them. Link.springer.com might have a hidden revenue stream, but it's not something we can detect.

Keywords {šŸ”}

pubmed, google, scholar, article, cas, cell, death, cells, apoptosis, central, expression, gbm, levels, glioblastoma, brain, signaling, astrocytes, ciap, apoptotic, human, casp, xiap, survivin, protein, fas, neurons, survival, cancer, neuronal, pathway, trail, tumor, injury, activation, neurosci, factor, cns, significantly, res, high, resistance, oligodendrocyte, pea, inhibition, mol, cflip, stem, bcl, increases, glioma,

Topics {āœ’ļø}

akt1/gsk-3β/β-catenin-trim11/survivin pathway tumor-necrosis-factor-related apoptosis-inducing-ligand tumour-necrosis-factor-related apoptosis-inducing ligand gsk-3β/β-catenin signaling c-jun n-terminal kinase tnf-related apoptosis-inducing ligand generate gbm-specific pericytes pi3k-nf-Īŗb-hif-1α-survivin pathway rabies virus glycoprotein-lactoferrin-liposomes granulocyte-colony stimulating factor tnf-jnk-axl-erk signaling axis wnt/β–catenin signaling pathway tropomyosin-related receptor kinase tumor necrosis factor-alpha tumor necrosis factor-α differentiated sh-sy5y cells brain-derived neurotrophic factor tnf-α-induced cell death glucocorticoid-induced tnfr-related death-inducing signaling complex nf-Īŗb p65-ciap2 link kappa b-binding factor glioblastoma-derived stem cells neural stem/progenitor cells article download pdf neuron-specific anti-apoptotic protein nf-Īŗb signaling mediates aav-mediated gene editing fas/fasl-induced cell death xiap-tableĀ 1-tak1 complex [467 dysregulated ras-mek-erk apoptosis-related gene expression transcription factor nf-Īŗb stem cell-based approaches apoptotic protease-activating factor-1 g1 cyclin-dependent kinases heavy anti-apoptotic skewing interferon-β sensitizes glioblastoma interferon-gamma-induced death death-receptor mediated death tumor-infiltrating immune cells tumor necrosis factor erk/map kinase pathway bh3 mimetic–induced apoptosis toxin-induced neuronal damage cerebellar granule cells fas ligand-induced apoptosis smac mimetic-induced upregulation nf-kappab-dependent regulation ectromelia virus-induced apoptosis

Questions {ā“}

  • , CD95 (Fas/Apo-1) as a receptor governing astrocyte apoptotic or inflammatory responses: a key role in brain inflammation?
  • Boulay, Notch signaling in glioblastoma: a developmental drug target?
  • Dhandapani, Astrocyte-specific expression of survivin after intracerebral hemorrhage in mice: a possible role in reactive gliosis?
  • Maellaro, Calpains and cancer: friends or enemies?

Schema {šŸ—ŗļø}

WebPage:
      mainEntity:
         headline:Cell death in glioblastoma and the central nervous system
         description:Glioblastoma is the commonest and deadliest primary brain tumor. Glioblastoma is characterized by significant intra- and inter-tumoral heterogeneity, resistance to treatment and dismal prognoses despite decades of research in understanding its biological underpinnings. Encompassed within this heterogeneity and therapy resistance are severely dysregulated programmed cell death pathways. Glioblastomas recapitulate many neurodevelopmental and neural injury responses; in addition, glioblastoma cells are composed of multiple different transformed versions of CNS cell types. To obtain a greater understanding of the features underlying cell death regulation in glioblastoma, it is important to understand the control of cell death within the healthy CNS during homeostatic and neurodegenerative conditions. Herein, we review apoptotic control within neural stem cells, astrocytes, oligodendrocytes and neurons and compare them to glioblastoma apoptotic control. Specific focus is paid to the Inhibitor of Apoptosis proteins, which play key roles in neuroinflammation, CNS cell survival and gliomagenesis. This review will help in understanding glioblastoma as a transformed version of a heterogeneous organ composed of multiple varied cell types performing different functions and possessing different means of apoptotic control. Further, this review will help in developing more glioblastoma-specific treatment approaches and will better inform treatments looking at more direct brain delivery of therapeutic agents.
         datePublished:2024-11-06T00:00:00Z
         dateModified:2024-11-06T00:00:00Z
         pageStart:313
         pageEnd:349
         license:http://creativecommons.org/licenses/by/4.0/
         sameAs:https://doi.org/10.1007/s13402-024-01007-8
         keywords:
            Apoptosis
            Necroptosis
            Glioblastoma
            Inhibitor of Apoptosis
            Astrocytes
            Oligodendrocytes
            Cancer Research
            Biomedicine
            general
            Pathology
            Oncology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-01007-8/MediaObjects/13402_2024_1007_Fig1_HTML.png
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-01007-8/MediaObjects/13402_2024_1007_Fig2_HTML.png
         isPartOf:
            name:Cellular Oncology
            issn:
               2211-3436
               2211-3428
            volumeNumber:48
            type:
               Periodical
               PublicationVolume
         publisher:
            name:Springer Netherlands
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Kyle Malone
               affiliation:
                     name:Children’s Hospital of Eastern Ontario Research Institute
                     address:
                        name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Ottawa
                     address:
                        name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Ottawa
                     address:
                        name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Ottawa
                     address:
                        name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Eric LaCasse
               affiliation:
                     name:Children’s Hospital of Eastern Ontario Research Institute
                     address:
                        name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Ottawa
                     address:
                        name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Shawn T. Beug
               affiliation:
                     name:Children’s Hospital of Eastern Ontario Research Institute
                     address:
                        name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Ottawa
                     address:
                        name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Ottawa
                     address:
                        name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
                     name:University of Ottawa
                     address:
                        name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Cell death in glioblastoma and the central nervous system
      description:Glioblastoma is the commonest and deadliest primary brain tumor. Glioblastoma is characterized by significant intra- and inter-tumoral heterogeneity, resistance to treatment and dismal prognoses despite decades of research in understanding its biological underpinnings. Encompassed within this heterogeneity and therapy resistance are severely dysregulated programmed cell death pathways. Glioblastomas recapitulate many neurodevelopmental and neural injury responses; in addition, glioblastoma cells are composed of multiple different transformed versions of CNS cell types. To obtain a greater understanding of the features underlying cell death regulation in glioblastoma, it is important to understand the control of cell death within the healthy CNS during homeostatic and neurodegenerative conditions. Herein, we review apoptotic control within neural stem cells, astrocytes, oligodendrocytes and neurons and compare them to glioblastoma apoptotic control. Specific focus is paid to the Inhibitor of Apoptosis proteins, which play key roles in neuroinflammation, CNS cell survival and gliomagenesis. This review will help in understanding glioblastoma as a transformed version of a heterogeneous organ composed of multiple varied cell types performing different functions and possessing different means of apoptotic control. Further, this review will help in developing more glioblastoma-specific treatment approaches and will better inform treatments looking at more direct brain delivery of therapeutic agents.
      datePublished:2024-11-06T00:00:00Z
      dateModified:2024-11-06T00:00:00Z
      pageStart:313
      pageEnd:349
      license:http://creativecommons.org/licenses/by/4.0/
      sameAs:https://doi.org/10.1007/s13402-024-01007-8
      keywords:
         Apoptosis
         Necroptosis
         Glioblastoma
         Inhibitor of Apoptosis
         Astrocytes
         Oligodendrocytes
         Cancer Research
         Biomedicine
         general
         Pathology
         Oncology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-01007-8/MediaObjects/13402_2024_1007_Fig1_HTML.png
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs13402-024-01007-8/MediaObjects/13402_2024_1007_Fig2_HTML.png
      isPartOf:
         name:Cellular Oncology
         issn:
            2211-3436
            2211-3428
         volumeNumber:48
         type:
            Periodical
            PublicationVolume
      publisher:
         name:Springer Netherlands
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Kyle Malone
            affiliation:
                  name:Children’s Hospital of Eastern Ontario Research Institute
                  address:
                     name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Ottawa
                  address:
                     name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Ottawa
                  address:
                     name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Ottawa
                  address:
                     name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Eric LaCasse
            affiliation:
                  name:Children’s Hospital of Eastern Ontario Research Institute
                  address:
                     name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Ottawa
                  address:
                     name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Shawn T. Beug
            affiliation:
                  name:Children’s Hospital of Eastern Ontario Research Institute
                  address:
                     name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Ottawa
                  address:
                     name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Ottawa
                  address:
                     name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
                  name:University of Ottawa
                  address:
                     name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Cellular Oncology
      issn:
         2211-3436
         2211-3428
      volumeNumber:48
Organization:
      name:Springer Netherlands
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:Children’s Hospital of Eastern Ontario Research Institute
      address:
         name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
         type:PostalAddress
      name:University of Ottawa
      address:
         name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
         type:PostalAddress
      name:University of Ottawa
      address:
         name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
         type:PostalAddress
      name:University of Ottawa
      address:
         name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
         type:PostalAddress
      name:Children’s Hospital of Eastern Ontario Research Institute
      address:
         name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
         type:PostalAddress
      name:University of Ottawa
      address:
         name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
         type:PostalAddress
      name:Children’s Hospital of Eastern Ontario Research Institute
      address:
         name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
         type:PostalAddress
      name:University of Ottawa
      address:
         name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
         type:PostalAddress
      name:University of Ottawa
      address:
         name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
         type:PostalAddress
      name:University of Ottawa
      address:
         name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Kyle Malone
      affiliation:
            name:Children’s Hospital of Eastern Ontario Research Institute
            address:
               name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
               type:PostalAddress
            type:Organization
            name:University of Ottawa
            address:
               name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
               type:PostalAddress
            type:Organization
            name:University of Ottawa
            address:
               name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
               type:PostalAddress
            type:Organization
            name:University of Ottawa
            address:
               name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
               type:PostalAddress
            type:Organization
      name:Eric LaCasse
      affiliation:
            name:Children’s Hospital of Eastern Ontario Research Institute
            address:
               name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
               type:PostalAddress
            type:Organization
            name:University of Ottawa
            address:
               name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
               type:PostalAddress
            type:Organization
      name:Shawn T. Beug
      affiliation:
            name:Children’s Hospital of Eastern Ontario Research Institute
            address:
               name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
               type:PostalAddress
            type:Organization
            name:University of Ottawa
            address:
               name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
               type:PostalAddress
            type:Organization
            name:University of Ottawa
            address:
               name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
               type:PostalAddress
            type:Organization
            name:University of Ottawa
            address:
               name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
      name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
      name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
      name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada
      name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
      name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
      name:Apoptosis Research Centre, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada
      name:Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Canada
      name:Centre for Infection, Immunity and Inflammation, University of Ottawa, Ottawa, Canada
      name:Ottawa Institute of Systems Biology, University of Ottawa, Ottawa, Canada

External Links {šŸ”—}(1648)

Analytics and Tracking {šŸ“Š}

  • Google Tag Manager

Libraries {šŸ“š}

  • Clipboard.js
  • Prism.js

CDN Services {šŸ“¦}

  • Crossref

7.86s.